For the TURQUOISE Ottawa COVID-19 study profiling immune responses of COVID-19 patients admitted to the intensive care unit (ICU), with a focus on the potential immunomodulatory function of mesenchymal stem cells.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Shirley Hsin-Ju MeiResearch Location
CanadaLead Research Institution
Ottawa Hospital Research InstituteResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
For the TURQUOISE Ottawa COVID-19 study profiling immune responses of COVID-19 patients admitted to the intensive care unit (ICU), with a focus on the potential immunomodulatory function of mesenchymal stem cells.